Heart Leaflet Technologies Valve Study
NCT00710775 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 7
Last updated 2009-10-12
Summary
The study will be conducted in patients who are undergoing surgical aortic valve replacement on cardiopulmonary bypass. Following surgical access of the native aortic valve and prior to removal of the valve, the native valve will be dilated using a standard valve dilation balloon. The Heart Leaflet Technologies(HLT- Heart Leaflet Technologies Inc.) aortic valve device will be released in the native valve and measurements will be taken of the device relative to the anatomic structures of the heart. Once completed, the implant is removed from the native valve and the surgical valve replacement procedure is completed.
The purpose of this study is to confirm that the dimensions of the HLT valve are appropriate for patients with aortic valve stenosis.
Conditions
- Aortic Valve Stenosis
- Endovascular Aortic Valve Replacement
Interventions
- PROCEDURE
-
surgical replacement of the aortic stenotic valve
Prior to surgical removal of the aortic valve, the native valve will be dilated under direct vision of the surgeon using a standard valve dilation balloon. The HLT valve will be loaded into a short version of the delivery catheter system and the catheter will be passed across the native valve.Measurements will be taken of the device relative to the anatomic structures of the heart. Once complete, the implant is removed from the native valve and the surgical valve replacement procedure is completed.
Sponsors & Collaborators
-
Centro Cardiologico Monzino
lead OTHER
Principal Investigators
-
Paolo Biglioli, MD · Centro Cardiologico Monzino-University of Milan
Study Design
- Allocation
- NON_RANDOMIZED
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 75 Years
- Max Age
- 80 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2007-11-30
- Primary Completion
- 2008-12-31
- Completion
- 2008-12-31
Countries
- Italy
Study Locations
More Related Trials
-
Xeltis Bioabsorbable Pulmonary Valved Conduit Pivotal Study
NCT03022708 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Pulmonary Valve Replacement in Large Right Ventricular Outflow Tract
NCT00259207 ·Status: COMPLETED ·Phase: PHASE3
-
Clinical Trial of Ventiflow LP Supporting High-risk Percutaneous Coronary Intervention(PCI)
NCT06754839 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
ProspeCtive, nOn-randoMized, MulticENter Clinical Evaluation of Edwards Pericardial Bioprostheses With a New Tissue Treatment Platform (COMMENCE)
NCT01757665 ·Status: COMPLETED ·Phase: NA
-
Early Feasibility Study of the Cardiovalve System for Tricuspid Regurgitation
NCT04100720 ·Status: WITHDRAWN ·Phase: NA
-
AltaValve Early Feasibility Study Protocol
NCT03997305 ·Status: UNKNOWN ·Phase: NA
-
A Multinational Trial To Evaluate The Parachute Implant System
NCT01286116 ·Status: TERMINATED ·Phase: PHASE3
-
Permanent Pacing for Drug-refractory Symptomatic Patients With Obstructive Hypertrophic Cardiomyopathy.
NCT05771987 ·Status: UNKNOWN ·Phase: NA
-
Xeltis Pulmonary Valved Conduit Safety and Performance Study
NCT03405636 ·Status: WITHDRAWN ·Phase: NA
-
Melody Transcatheter Pulmonary Valve Study: Post Approval Study of the Investigational Device Exemption Cohort
NCT00740870 ·Status: COMPLETED ·Phase: NA
-
Early Feasibility Study for the Foldax TRIA Mitral Heart Valve Replacement
NCT04717570 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
The Feasibility Study of Polymer Artificial Heart Valve for the Treatment the Mitral Valve Disease.
NCT07243184 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Feasibility Study of Patients With Severe MR Treated With the Cardiovalve TMVR System
NCT03714412 ·Status: WITHDRAWN ·Phase: NA
-
Evaluation of the HeartWare Left Ventricular Assist Device for the Treatment of Advanced Heart Failure
NCT00751972 ·Status: COMPLETED ·Phase: NA
-
Observational Study of the Heart Repair Technologies Mitral Bridge in Treating Mitral Valve Regurgitation
NCT03511716 ·Status: TERMINATED
-
Study to Assess Safety of the Pulmonary Valved Conduit (PV-001) in Subjects Undergoing Right Ventricular Outflow Tract Reconstruction
NCT02700100 ·Status: UNKNOWN ·Phase: NA
-
HLT® Meridian® TAVR Valve System Early Feasibility Study for Aortic Regurgitation
NCT05409378 ·Status: WITHDRAWN ·Phase: NA
-
First in Man Study of Implantable Alginate Hydrogel
NCT04781660 ·Status: UNKNOWN ·Phase: NA
-
Study of Percutaneous Renal Artery Intervention for Patient With Heart Failure
NCT01403714 ·Status: WITHDRAWN ·Phase: NA
-
NHLBI DIR LAMPOON Study: Intentional Laceration of the Anterior Mitral Leaflet to Prevent Left Ventricular Outflow Tract Obstruction During Transcatheter Mitral Valve Implantation
NCT03015194 ·Status: COMPLETED ·Phase: NA
-
Phase II Clinical Trial of Percutaneous Ventricular Restoration Using Heartech® Device Preventing Heart Failure Post Myocardial Infarction (The Partical Study)
NCT04039256 ·Status: UNKNOWN ·Phase: NA
-
Transapical Implantation of Ventor Embracer™ Valve in Patients With Severe Aortic Valve Disease
NCT00677638 ·Status: UNKNOWN ·Phase: NA
-
Mitroflow DL Post Approval Study- North America
NCT02351726 ·Status: TERMINATED ·Phase: NA
-
Non Interventional Study on Pulmonary Valve Replacement by Thranscatheter Pulmonary Valve Melody™
NCT02023775 ·Status: COMPLETED
-
ChordArt System for Mitral Regurgitation
NCT03581656 ·Status: UNKNOWN ·Phase: NA